UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1553) 1553
life sciences & biomedicine (1538) 1538
humans (1537) 1537
male (1245) 1245
gabapentin (1038) 1038
female (927) 927
cyclohexanecarboxylic acids - therapeutic use (803) 803
animals (762) 762
gamma-aminobutyric acid - therapeutic use (726) 726
amines - therapeutic use (707) 707
cyclohexanecarboxylic acids - administration & dosage (643) 643
adult (617) 617
middle aged (614) 614
gamma-aminobutyric acid - administration & dosage (542) 542
amines - administration & dosage (530) 530
cyclohexanecarboxylic acids (527) 527
amines (470) 470
neurosciences & neurology (467) 467
cyclohexanecarboxylic acids - pharmacology (445) 445
gamma-aminobutyric acid (427) 427
analgesics - therapeutic use (421) 421
rats (413) 413
treatment outcome (412) 412
pharmacology & pharmacy (407) 407
dose-response relationship, drug (364) 364
aged (359) 359
analgesics - administration & dosage (348) 348
clinical neurology (330) 330
neurosciences (279) 279
anticonvulsants - therapeutic use (278) 278
gamma-aminobutyric acid - pharmacology (273) 273
acetates - therapeutic use (263) 263
amines - pharmacology (260) 260
pain (255) 255
abridged index medicus (251) 251
cyclohexanecarboxylic acids - adverse effects (249) 249
double-blind method (244) 244
anesthesiology (240) 240
gamma-aminobutyric acid - adverse effects (236) 236
drug therapy, combination (235) 235
amines - adverse effects (227) 227
pain measurement (218) 218
care and treatment (217) 217
mice (208) 208
anticonvulsants - administration & dosage (207) 207
rats, sprague-dawley (206) 206
administration, oral (193) 193
acetates - administration & dosage (192) 192
neuralgia - drug therapy (188) 188
disease models, animal (183) 183
adolescent (174) 174
time factors (172) 172
drug administration schedule (169) 169
gamma-aminobutyric acid - analogs & derivatives (168) 168
pain - drug therapy (167) 167
general & internal medicine (164) 164
pregabalin (158) 158
analgesics - pharmacology (157) 157
medicine, general & internal (153) 153
neuropathic pain (153) 153
analysis (151) 151
anticonvulsants - adverse effects (151) 151
drug therapy (147) 147
psychiatry (133) 133
analgesics (121) 121
analgesics - adverse effects (119) 119
medicine & public health (119) 119
cyclohexanecarboxylic acids - pharmacokinetics (117) 117
pain, postoperative - drug therapy (116) 116
dosage and administration (114) 114
anticonvulsants - pharmacology (113) 113
acetates - pharmacology (110) 110
research (110) 110
prospective studies (108) 108
epilepsy - drug therapy (105) 105
acetates - adverse effects (103) 103
anticonvulsants (103) 103
epilepsy (103) 103
analgesics, opioid - therapeutic use (100) 100
drug interactions (98) 98
gamma-aminobutyric acid - pharmacokinetics (97) 97
neurology (97) 97
randomized controlled trials as topic (96) 96
pain, postoperative - prevention & control (95) 95
rats, wistar (95) 95
aged, 80 and over (94) 94
amines - pharmacokinetics (93) 93
surgery (92) 92
anticonvulsants - pharmacokinetics (89) 89
child (89) 89
hyperalgesia - drug therapy (89) 89
pain measurement - drug effects (89) 89
clinical trials (88) 88
internal medicine (88) 88
young adult (88) 88
pain - etiology (84) 84
retrospective studies (84) 84
pain management (81) 81
clinical trials as topic (79) 79
fructose - analogs & derivatives (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2086) 2086
Japanese (48) 48
German (43) 43
Spanish (22) 22
Italian (13) 13
French (8) 8
Danish (5) 5
Portuguese (5) 5
Turkish (5) 5
Polish (4) 4
Russian (4) 4
Chinese (3) 3
Norwegian (3) 3
Finnish (2) 2
Hungarian (2) 2
Swedish (2) 2
Dutch (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Archives of toxicology, ISSN 0340-5761, 1/2017, Volume 91, Issue 1, pp. 179 - 188
Journal Article
Cochrane library, ISSN 1465-1858, 06/2017, Volume 2020, Issue 2, pp. CD007938 - CD007938
... (any route of administration) with placebo or another active treatment for neuropathic pain, with participant... 
Amines | Soft tissue disorders | Gabapentin | Fibromyalgia | 2019 3. Chronic pain | Peripheral neuropathy | Analgesics | Painful neuropathy (Shared area of common interest with Pain, Palliative and Supportive Care (PaPaS) Group) | Fibromylagia | Neuralgia, Postherpetic | Pharmacological therapies | Chronic Pain | gamma‐Aminobutyric Acid | Anti‐epileptic drug treatment (Please refer to the PaPaS Group) | Rheumatology | [R] PaPaS Group ‐ Gabapentin for acute and chronic pain | Painful neuropathy | Management | Pain & anaesthesia | Diabetic Neuropathies | Randomized Controlled Trials as Topic | Neurology | Chronic non‐cancer pain | Numbers Needed To Treat | 2019 3.1 Neuropathic pain | Cyclohexanecarboxylic Acids | Neuralgia | Medicine General & Introductory Medical Sciences | Chronic Disease | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Chronic Pain - drug therapy | Humans | Cyclohexanecarboxylic Acids - adverse effects | Analgesics - administration & dosage | Cyclohexanecarboxylic Acids - administration & dosage | gamma-Aminobutyric Acid - administration & dosage | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Neuralgia - drug therapy | Fibromyalgia - drug therapy | Amines - administration & dosage | Adult | Amines - adverse effects | Analgesics - adverse effects | gamma-Aminobutyric Acid - adverse effects | Index Medicus
Journal Article
Pharmaceutical research, ISSN 0724-8741, 3/2015, Volume 32, Issue 3, pp. 898 - 909
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2012, Volume 380, Issue 9853, pp. 1583 - 1589
Journal Article
Journal of neurology, ISSN 0340-5354, 3/2010, Volume 257, Issue 3, pp. 322 - 327
A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy... 
Neurology | Neurosciences | Multiple sclerosis | Memantine | Medicine & Public Health | Gabapentin | Acquired nystagmus | Drug therapy | Neuroradiology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Single-Blind Method | Neural Pathways - drug effects | Prospective Studies | Humans | Middle Aged | Clinical Protocols | Male | gamma-Aminobutyric Acid - administration & dosage | Eye Movements - drug effects | Brain Stem - drug effects | Dose-Response Relationship, Drug | Young Adult | Amines - administration & dosage | Adult | Female | Amines - adverse effects | Nystagmus, Pathologic - etiology | Neural Pathways - physiopathology | Excitatory Amino Acid Antagonists - adverse effects | Memantine - administration & dosage | Nystagmus, Pathologic - drug therapy | gamma-Aminobutyric Acid - adverse effects | Eye Movements - physiology | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Nystagmus, Pathologic - physiopathology | Cross-Over Studies | Multiple Sclerosis - complications | Brain Stem - physiopathology | Memantine - adverse effects | Complications and side effects | Nystagmus | Causes of | Dosage and administration | Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2/2018, Volume 41, Issue 2, pp. 213 - 228
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 01/2010, Volume 9, Issue 1, pp. 157 - 166
Journal Article